Home
Proteros

Proteros Market Share Analysis for June 2026

Meet the Proteros leadership team, dedicated to helping you reach right faster.

Industry: N/A

Domainproteros.com

Year Founded2000

Employees51 - 200

Annual Revenue$15M - $25M

Proteros

Proteros (including company regionals)

proteros.com

See more website traffic and engagement information

Proteros Revenue up to June 2026 is 15M - 25M

revenue generated by Proteros top domains

Proteros top domains revenue over 3 years

Revenue for Proteros top domains

proteros.com15M - 25M

See more with Sales Intelligence

Total visits to Proteros's top domains

Understand Proteros market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

proteros.com4.4K

See more with Sales Intelligence

Avg. visit duration in Proteros's top domains

Analyze Proteros engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

proteros.com00:02:07

See more with Sales Intelligence

Avg. pageviews on Proteros's top domains

See how Proteros keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

proteros.com1.88

See more with Sales Intelligence

Proteros top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Proteros

These are the website technologies, by industry, used by Proteros top domains

Advertising (3)

PubMatic

Conversion & Analytics (3)

Google Analytics

Payment & Currencies (3)

Visa

Widget (3)

Google Maps

More Technologies

8

See all

News & Signals from Proteros

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsProteros biostructures GmbH partners with Orion Corporation.Proteros Biostructures GmbH has established a new collaboration with Orion Corp.

NewsAdrestia Therapeutics Ltd partnered with Proteros biostructures GmbH on Oct 25th '22.Adrestia Therapeutics, a leader in synthetic rescue therapies for genetic diseases, today announced the appointment of Dr James Osborne as Head of Chemistry and the initiation of a multi-target partnership with Proteros biostructures GmbH (Munich, Germany) to accelerate the discovery of first-in-class candidate drugs for intractable diseases.

NewsProteros biostructures GmbH partners with Thermo Fisher Scientific.Proteros is collaborating with Thermo Fisher Scientific to develop the experimental methods, protein sample preparation processes and workflows.